Joe Cunning Joins Kraig Biocraft Laboratories Business Advisory Board
January 24 2011 - 6:05AM
Marketwired
Kraig Biocraft Laboratories, Inc. (PINKSHEETS: KBLB) announced
today that Dr. Joe Cunning, a leading figure in the textile
industry and member of the Textile Institute's governing board,
with 45 years of experience in the fibers, textile and apparel
industry, has joined the Company's Board of Advisors.
For the last 20 years Dr. Cunning has been the President of
Cunning & Associates, Ltd., a leading textile industry
consulting firm. He also completed a highly successful 28 year
career at DuPont, where he headed the pioneering research
laboratory in Wilmington, and was in charge of worldwide research
on all fiber types. His manufacturing experience included worldwide
responsibility for non-woven products, as well as polyester
filament and staple fibers.
Dr. Cunning was awarded the Textile Institute's Medal for
outstanding contribution to the industry in 2000 and in 2010 he was
presented with the Textile Institute's Companion Membership award,
as one of fifty living persons who have made a significant impact
on the textile industry.
In addition to his work on various corporate boards, Dr. Cunning
served on the governing boards of the Fiber Society, vice-president
of the Textile Institute, the Technical Advisory Committee, and on
the board of governors of the Iowa State University Foundation. In
1992, Cunning was named the National Textile Center's (a research
consortium of eight universities) first Executive Director, a post
he held for 12 years.
"Dr Cunning brings a wealth of knowledge and textile industry
expertise, which is exactly what we need as we move to
commercialize our laboratory discoveries," said Kraig Biocraft
Laboratories founder and CEO, Kim K. Thompson. "He is highly
respected by the industry leaders, which I believe will be
instrumental as we seek new opportunities and partnerships."
"Joe's Textile Institute Companion Membership induction is a
testament to his remarkable textile industry accomplishments and
his innovative leadership record. We are fortunate to attract
someone with his level of expertise, and talent, for his new role
with the Company."
Kraig Biocraft Laboratories is a fully reporting biotechnology
company that recently achieved a series of scientific
breakthroughs, with implications for the global textile industry.
For further information, including videos, which outline the
commercial potential that has garnered attention of many scientific
and trade journals, please visit www.KraigLabs.com.
Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "hopes," "develops," "researching," "research,"
"potential," "implications," "could" or other words or phrases of
similar import. Similarly, statements in this release that describe
the Company's business strategy, outlook, objectives, plans,
intentions or goals should all be considered forward-looking
statements. All such forward-looking statements are subject to
certain risks and uncertainties that could cause actual results to
differ materially from those in forward-looking statements.
Management cautions that its ability to further its research, and
create commercially-viable products may be affected by the
competitive environment, the Company's financial condition and its
ability to raise sufficient capital to meet the financial
obligations of its business plan and to fund its continuing
operations.
Contact: Ben Hansel (720) 288-8495
http://www.linkedin.com/pub/joe-cunning/7/478/392
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From May 2024 to Jun 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Jun 2023 to Jun 2024